Here’s whether Edwards Lifesciences Corp (EW) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); RSI 58 — healthy momentum range; strong 1-year return of +13.8%. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-0.73% over 10 days). Currently 7.8% off its 52-week high. Score: +2/7.
EW is holding above its long-term 200-day MA ($80.81) but has slipped below the 50-day MA ($81.28), pointing to short-term weakness in an otherwise intact trend. An RSI of 57.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +13.8% compares to +35.1% for SPY (trailed the market by 21.3%).
$10,000 invested 1 year ago→ $11,375 today
vs. S&P 500 (SPY) — same period trailed market by 21.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($80.81)
✗Above 50-day MA ($81.28)
✓RSI(14) neutral zone (30–70) — currently 57.9
✓Positive return (+13.8%)
✓Within 10% of period high (−7.8%)
Period Range $80.99
$68.63$87.89
RSI (14) 57.9
0 · OversoldOverbought · 100
Key Metrics
Price$80.99
Period Return+13.8%
Period High$87.89
Period Low$68.63
Drawdown−7.8%
MA-50$81.28
MA-200$80.81
RSI (14)57.9
Avg Volume (30d)4.7M
vs. SPYtrailed by 21.3%
Return Rank#599 of 996
Trend Signals
Price is above the 200-day moving average ($80.81)